Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant mixed mesodermal tumours with peritoneal dissemination

Eur J Surg Oncol. 2005 Feb;31(1):111-2. doi: 10.1016/j.ejso.2004.09.001.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Chemotherapy, Cancer, Regional Perfusion*
  • Combined Modality Therapy
  • Female
  • Humans
  • Hyperthermia, Induced*
  • Ifosfamide / administration & dosage
  • Laparotomy
  • Liver / pathology
  • Mitomycin / administration & dosage
  • Mixed Tumor, Malignant / secondary*
  • Mixed Tumor, Malignant / therapy*
  • Mixed Tumor, Mesodermal / secondary*
  • Mixed Tumor, Mesodermal / therapy*
  • Neoplasm Recurrence, Local / therapy
  • Neoplasm Staging
  • Peritoneal Cavity / pathology
  • Peritoneal Neoplasms / pathology*
  • Peritoneal Neoplasms / therapy*
  • Treatment Outcome
  • Women's Health

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents, Alkylating
  • Mitomycin
  • Ifosfamide